147 results
8-K
nu6i9h7p447 3ts
31 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:19pm
8-K
EX-10.4
0kt3nz
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.3
ocs4x47c06o3sy
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.2
f0oo ymdq
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
425
bd9 8nx3ustibjj
30 May 23
Business combination disclosure
4:21pm
8-K
3v0g9i39
30 May 23
Submission of Matters to a Vote of Security Holders
4:18pm
425
n0yafv fd764fphbnef
22 May 23
Business combination disclosure
7:01am
8-K
q7vx1kmv9mgmunqp
22 May 23
Other Events
6:59am